HTRA2 and glaucoma: However, in a recent study by our group, it was demonstrated that the synthetic CDR1 peptide ASGYTFTNYGLSWVR induced neuroprotection on retinal ganglion cells (RGC) in an in vitro glaucoma model and possessed a high affinity for the target protein HTRA2, verified by immunoprecipitation experiments [16].